Federal Reserve officials take great pains not to comment on fiscal policy, but the looming threat from tariffs is forcing their hand.
Related Posts
Assad regime on brink of collapse in Syria as rebel forces claim Damascus
The defense forces of the Russia and Iran-backed Assad government have been struggling to stave off the lightning advance of rebel forces.
Jefferies says buy this pharmaceutical play, sees more than 100% upside from here
This pharmaceutical company’s recent drug developments could spell more gains ahead, according to Jefferies.
Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.